Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › GARDEN GROVE › PATHLAB SERVICES INC

PATHLAB SERVICES INC

NPI: 1447557822 · GARDEN GROVE, CA 92841 · Clinical Medical Laboratory · NPI assigned 02/19/2011

$6.97M
Total Medicaid Paid
185,394
Total Claims
148,867
Beneficiaries
102
Codes Billed
2018-05
First Month
2023-06
Last Month

Provider Details

Authorized OfficialHISERODT, JOHN (PRESIDENT)
NPI Enumeration Date02/19/2011

Related Entities

Other providers sharing the same authorized official: HISERODT, JOHN

ProviderCityStateTotal Paid
DIAGNOSTIC LABORATORY SCIENCE, INC GARDEN GROVE CA $7.69M
CENTRAL MEDICAL DIAGNOSTIC LABORATORY,INC. CYPRESS CA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 45,682 $1.09M
2019 9,879 $457K
2020 36,029 $1.51M
2021 51,585 $2.17M
2022 37,726 $1.47M
2023 4,493 $267K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 38,604 25,023 $2.07M
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 22,893 16,431 $1.87M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 17,604 11,130 $602K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 12,601 12,593 $387K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 12,613 12,605 $386K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 3,137 2,804 $314K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1,471 1,444 $263K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 17,116 12,748 $221K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 9,163 9,162 $183K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 10,394 6,299 $140K
87486 2,950 2,820 $64K
87631 1,481 1,389 $53K
87581 2,952 2,821 $53K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 852 802 $44K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,127 1,015 $36K
86592 9,181 9,181 $35K
87634 643 592 $30K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 695 675 $24K
87541 867 816 $20K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,229 1,223 $18K
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source 743 418 $14K
86769 244 243 $13K
87081 395 388 $11K
80053 Comprehensive metabolic panel 1,617 1,578 $9K
84443 Thyroid stimulating hormone (TSH) 1,059 1,052 $9K
84481 630 630 $8K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 200 194 $7K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,881 1,846 $7K
80061 Lipid panel 1,028 1,021 $6K
84432 441 441 $6K
84439 1,020 1,014 $5K
86800 421 420 $5K
86376 436 436 $5K
83036 Hemoglobin; glycosylated (A1C) 1,127 1,113 $5K
86481 56 56 $3K
88142 162 162 $3K
86780 328 327 $2K
80074 74 72 $2K
84403 123 123 $2K
87507 421 421 $2K
87505 51 47 $1K
82607 123 123 $1K
84402 68 68 $1K
87070 276 273 $1K
82172 50 50 $1K
84550 302 301 $1K
87077 440 430 $1K
84270 68 68 $1K
87807 190 189 $1K
84480 97 97 $1K
82627 65 65 $981.49
82746 101 100 $963.80
84305 65 65 $934.20
87086 Culture, bacterial; quantitative colony count, urine 253 244 $823.46
87088 290 286 $801.66
83090 69 69 $797.28
81000 469 455 $754.34
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 33 32 $735.68
82533 65 65 $719.82
82728 70 70 $609.07
83695 62 62 $592.64
81001 216 211 $568.52
87481 58 55 $511.79
83525 66 66 $499.25
86696 30 30 $474.25
83721 77 77 $437.65
80050 General health panel 136 135 $412.66
87500 61 58 $398.30
87640 59 56 $398.22
84436 74 74 $382.72
83540 99 99 $380.43
87653 59 55 $375.54
83550 66 66 $372.01
84153 41 40 $347.09
83690 77 77 $344.93
82248 95 95 $326.52
86695 30 30 $325.06
83735 82 82 $302.33
82550 65 65 $287.10
82150 64 64 $275.83
84479 47 47 $242.03
86140 66 66 $226.61
85007 82 80 $219.02
88305 Level IV - Surgical pathology, gross and microscopic examination 13 12 $203.31
86708 16 16 $162.08
87184 87 86 $159.46
86704 16 16 $156.00
86706 16 16 $136.96
80164 14 14 $131.48
86403 52 50 $129.35
84146 12 12 $115.05
82043 18 18 $81.70
86430 17 17 $69.44
86141 16 16 $66.59
86593 13 13 $51.00
85651 53 53 $46.34
87210 12 12 $42.72
85730 30 29 $37.46
85610 30 29 $24.31
84460 14 14 $18.12
84450 14 14 $17.48
36415 Collection of venous blood by venipuncture 115 115 $6.00